Tianjin Ringpu Bio-Technology Co.,Ltd.

SZSE:300119 Stock Report

Market Cap: CN¥6.5b

Tianjin Ringpu Bio-TechnologyLtd Past Earnings Performance

Past criteria checks 4/6

Tianjin Ringpu Bio-TechnologyLtd has been growing earnings at an average annual rate of 16.4%, while the Pharmaceuticals industry saw earnings growing at 9.2% annually. Revenues have been growing at an average rate of 10% per year. Tianjin Ringpu Bio-TechnologyLtd's return on equity is 10.6%, and it has net margins of 19.7%.

Key information

16.4%

Earnings growth rate

12.6%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate10.0%
Return on equity10.6%
Net Margin19.7%
Last Earnings Update31 Mar 2024

Recent past performance updates

Impressive Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)

Apr 05
Impressive Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)

Recent updates

Impressive Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)

Apr 05
Impressive Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)

Tianjin Ringpu Bio-Technology Co.,Ltd.'s (SZSE:300119) Subdued P/E Might Signal An Opportunity

Mar 28
Tianjin Ringpu Bio-Technology Co.,Ltd.'s (SZSE:300119) Subdued P/E Might Signal An Opportunity

Revenue & Expenses Breakdown

How Tianjin Ringpu Bio-TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300119 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 242,339460563177
31 Dec 232,249453555172
30 Sep 232,195387548182
30 Jun 232,170385531160
31 Mar 232,136355518143
01 Jan 232,084347507132
30 Sep 221,985354555105
30 Jun 221,875349530113
31 Mar 221,838369511114
01 Jan 222,007413547117
30 Sep 212,038438522124
30 Jun 212,117454548120
31 Mar 212,106441552116
31 Dec 202,000398551111
30 Sep 201,895302549102
30 Jun 201,73725552797
31 Mar 201,61322449594
31 Dec 191,46719444094
30 Sep 191,34615839989
30 Jun 191,26013737384
31 Mar 191,20312437379
31 Dec 181,19011936080
30 Sep 181,17910837181
30 Jun 181,157117301123
31 Mar 181,112112321105
31 Dec 171,04710534385
30 Sep 171,00813634161
30 Jun 179931384020
31 Mar 179881403980
31 Dec 169701333910
30 Sep 169431293570
30 Jun 169051133640
31 Mar 168321083370
31 Dec 157931103340
30 Sep 15690683300
30 Jun 15639433400
31 Mar 15625343460
31 Dec 14585273270
30 Sep 14669953230
30 Jun 146761133040
31 Mar 147221402990
31 Dec 137551523020
30 Sep 137241492710
30 Jun 137021482630

Quality Earnings: 300119 has a large one-off gain of CN¥203.6M impacting its last 12 months of financial results to 31st March, 2024.

Growing Profit Margin: 300119's current net profit margins (19.7%) are higher than last year (16.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300119's earnings have grown by 16.4% per year over the past 5 years.

Accelerating Growth: 300119's earnings growth over the past year (29.4%) exceeds its 5-year average (16.4% per year).

Earnings vs Industry: 300119 earnings growth over the past year (29.4%) exceeded the Pharmaceuticals industry -0.8%.


Return on Equity

High ROE: 300119's Return on Equity (10.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.